Zurich Cantonal Bank’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.02M | Sell |
111,546
-16,668
| -13% | -$601K | 0.01% | 641 |
|
|
2025
Q1 | $3.99M | Sell |
128,214
-47,438
| -27% | -$1.48M | 0.01% | 635 |
|
|
2024
Q4 | $4.48M | Buy |
175,652
+18,207
| +12% | +$464K | 0.01% | 621 |
|
|
2024
Q3 | $4.44M | Sell |
157,445
-6,489
| -4% | -$183K | 0.01% | 603 |
|
|
2024
Q2 | $4.37M | Sell |
163,934
-7,727
| -5% | -$206K | 0.01% | 580 |
|
|
2024
Q1 | $5.23M | Buy |
171,661
+31,249
| +22% | +$952K | 0.02% | 540 |
|
|
2023
Q4 | $3.94M | Sell |
140,412
-69,164
| -33% | -$1.94M | 0.02% | 588 |
|
|
2023
Q3 | $5.61M | Buy |
209,576
+90,282
| +76% | +$2.42M | 0.02% | 488 |
|
|
2023
Q2 | $3.65M | Buy |
119,294
+32,161
| +37% | +$983K | 0.02% | 581 |
|
|
2023
Q1 | $3.16M | Buy |
87,133
+18,609
| +27% | +$676K | 0.02% | 595 |
|
|
2022
Q4 | $2.71M | Buy |
68,524
+8,963
| +15% | +$354K | 0.01% | 608 |
|
|
2022
Q3 | $2.39M | Buy |
59,561
+10,319
| +21% | +$415K | 0.01% | 625 |
|
|
2022
Q2 | $2.07M | Sell |
49,242
-36
| -0.1% | -$1.51K | 0.01% | 668 |
|
|
2022
Q1 | $1.92M | Buy |
49,278
+13,787
| +39% | +$537K | 0.01% | 732 |
|
|
2021
Q4 | $1.41M | Buy |
35,491
+6,221
| +21% | +$248K | 0.01% | 860 |
|
|
2021
Q3 | $1.07M | Sell |
29,270
-143
| -0.5% | -$5.25K | 0.01% | 904 |
|
|
2021
Q2 | $1.21M | Hold |
29,413
| – | – | 0.01% | 842 |
|
|
2021
Q1 | $1.28M | Buy |
29,413
+5,142
| +21% | +$224K | 0.01% | 812 |
|
|
2020
Q4 | $1.22M | Buy |
+24,271
| New | +$1.22M | 0.01% | 880 |
|